A Case of Severe QTc Prolongation During Targeted Temperature Management– What Can We Learn?

Abstract

Patient: Female, 57-year-old

Final Diagnosis: Stroke

Symptoms: Aphasia • facial droop • weaknes of lower limbs

Medication:—

Clinical Procedure: Targeted temperature management

Specialty: Cardiology • Critical Care Medicine

Objective:

Unusual or unexpected effect of treatment

Background:

QTc prolongation during targeted temperature management (TTM) post cardiac arrest is a known effect of hypothermia, but its significance is unclear. Several studies suggest that temporary prolongation during TTM is not prognostic and does not potentiate fatal arrhythmias; however, there are limited cases of patients presenting with QTc intervals >700 milliseconds.

Case Report:

We describe a case in which a 57-year-old woman with diabetes, hypertension, and atrial fibrillation presented with concern for stroke. The hospital course was complicated by cardiac arrest requiring TTM, which was stopped early due to significant QTc prolongation of 746 milliseconds.

Conclusions:

TTM is beneficial post resuscitation for good neurological outcomes, but it also has known adverse cardiac effects such as QTc prolongation. The significance of QTc prolongation during TTM is unclear as several studies have shown no increased incidence of malignant arrhythmias. One case report in the literature describes the incidence of torsades de pointes due to QTc prolongation during TTM. Further study and guidelines regarding electrocardiogram monitoring are needed to determine the importance of QTc prolongation during TTM.